Sponsor:
Oliver Jonas
Code:
NCT07892300
Conditions
Lung Cancer
Mesothelioma
Suspected Lung Cancer
Suspected Mesothelioma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Implantable Micro- drug delivery Microdevice (IMD)
Brief summary:
Conditions
Lung Cancer
Mesothelioma
Suspected Lung Cancer
Suspected Mesothelioma
Study ID
NCT07892300
Start date
Nov 16, 2026
Status verified date
Nov, 2026
Completion date
Nov 30, 2031
Anticipated
Primary completion date
Nov 16, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
experimental: Implantable Microdevice (IMD) + Standard-of-care Surgical Retrieval + Standard-of-Care Treatment
Interventions
Implantable Micro- drug delivery Microdevice (IMD)
Primary outcome measure
Central contacts
Locations
Brigham and Women's Hospital
Recruiting
Boston, Massachusetts, United States, 02115
Contacts
Sponsor
Oliver Jonas
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Oliver Jonas on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.